SALTEROL 500 DPICAPS

Product Description

SALTEROL 500 DPICAPS is a premium inhalation therapy formulation combining Salmeterol 50mcg, a long-acting bronchodilator, and Fluticasone Propionate 500mcg, a potent corticosteroid. Designed for effective respiratory management, this dual-action dry powder capsule is ideal for the long-term treatment of asthma and chronic obstructive pulmonary disease (COPD).

Engineered for precise pulmonary delivery, SALTEROL 500 DPICAPS ensures prolonged bronchodilation, reduced airway inflammation, and improved lung function. It is a reliable choice for hospital procurement, pharmacy chains, and bulk pharmaceutical distributors seeking high-quality respiratory care solutions.

Key Benefits:

• Dual-action therapy for asthma and COPD management

• Enhances airflow and reduces bronchial inflammation

• Dry powder capsule format ensures accurate dosage and patient adherence

• Manufactured in WHO-GMP certified facilities for consistent quality

Indications & Usage:

• Maintenance treatment of moderate to severe asthma

• First-line therapy for COPD with frequent exacerbations

• Recommended in pulmonology and respiratory care settings

Why Choose SALTEROL 500 DPICAPS?

• Trusted combination of Salmeterol and Fluticasone

• Ideal for bulk purchase, institutional supply, and export orders

• Backed by regulatory compliance and quality assurance protocols